TY - JOUR
T1 - The “Complex Restrictive” Pulmonary Function Pattern
T2 - Clinical and Radiologic Analysis of a Common but Previously Undescribed Restrictive Pattern
AU - Clay, Ryan D.
AU - Iyer, Vivek N.
AU - Reddy, Dereddi Raja
AU - Siontis, Brittany
AU - Scanlon, Paul D.
N1 - Funding Information:
Financial/nonfinancial disclosures: The authors have reported to CHEST the following: P. D. S. has served as an investigator for clinical trials sponsored by AstraZeneca, Boehringer Ingelheim, Forest, GlaxoSmithKline, Novartis, Pearl, and Pfizer, as well as studies funded by the National Heart, Lung and Blood Institute and the Department of Defense; he has served on scientific advisory panels for GlaxoSmithKline and Boehringer Ingelheim. None declared (R. D. C., V. N. I., D. R. R., B. S.).
Publisher Copyright:
© 2017 American College of Chest Physicians
PY - 2017/12
Y1 - 2017/12
N2 - Background Most patients with restriction have a pulmonary function test (PFT) pattern in which total lung capacity (TLC), FVC, and FEV1 are reduced to a similar degree. This pattern is called “simple restriction” (SR). In contrast, we commonly observe a pattern in which FVC percent predicted (pp) is disproportionately reduced relative to TLCpp. This pattern is termed “complex restriction” (CR), and we attempted to characterize its clinical, radiologic, and physiologic features. Methods This study reviewed PFT results of patients tested between November 2009 and June 2013 who had restriction (TLC less than the lower limit of normal). SR was defined as TLCpp-FVCpp ≤ 10%, and CR was stratified into four classes based on TLCpp-FVCpp discrepancy: Class 1 CR, TLCpp-FVCpp > 10% and ≤ 15%; Class 2 CR, TLCpp-FVCpp > 15% and ≤20%; Class 3 CR, TLCpp-FVCpp > 20% and ≤ 25%; and Class 4 CR, TLCpp-FVCpp > 25%. The medical records of 150 randomly selected patients with SR and 50 patients from each CR class were reviewed. Results Of 39,277 PFTs completed, we identified 4,532 patients (11.5%) with restriction: 2,407 (6.1%) with SR, 1,614 (4.1%) with CR, and 511 (1.3%) with a mixed pattern. Patients with CR were younger, were more often women, and had a higher prevalence of neuromuscular disease, BMI > 40 kg/m2 or < 18.5 kg/m2, diaphragmatic dysfunction, bronchiectasis, CT mosaic attenuation, and pulmonary hypertension (P <.0001, <.0001, <.001,.004,.0008,.002,.008,.009,.053, and.01, respectively) and a lower prevalence of interstitial lung disease (P <.0001). Conclusions CR is a common PFT pattern with distinct clinical features. The associated clinical entities share impaired lung emptying (eg, neuromuscular disease, occult obstruction, chest wall limitation). Clinicians should be aware of this novel PFT pattern and how it shapes the differential diagnosis.
AB - Background Most patients with restriction have a pulmonary function test (PFT) pattern in which total lung capacity (TLC), FVC, and FEV1 are reduced to a similar degree. This pattern is called “simple restriction” (SR). In contrast, we commonly observe a pattern in which FVC percent predicted (pp) is disproportionately reduced relative to TLCpp. This pattern is termed “complex restriction” (CR), and we attempted to characterize its clinical, radiologic, and physiologic features. Methods This study reviewed PFT results of patients tested between November 2009 and June 2013 who had restriction (TLC less than the lower limit of normal). SR was defined as TLCpp-FVCpp ≤ 10%, and CR was stratified into four classes based on TLCpp-FVCpp discrepancy: Class 1 CR, TLCpp-FVCpp > 10% and ≤ 15%; Class 2 CR, TLCpp-FVCpp > 15% and ≤20%; Class 3 CR, TLCpp-FVCpp > 20% and ≤ 25%; and Class 4 CR, TLCpp-FVCpp > 25%. The medical records of 150 randomly selected patients with SR and 50 patients from each CR class were reviewed. Results Of 39,277 PFTs completed, we identified 4,532 patients (11.5%) with restriction: 2,407 (6.1%) with SR, 1,614 (4.1%) with CR, and 511 (1.3%) with a mixed pattern. Patients with CR were younger, were more often women, and had a higher prevalence of neuromuscular disease, BMI > 40 kg/m2 or < 18.5 kg/m2, diaphragmatic dysfunction, bronchiectasis, CT mosaic attenuation, and pulmonary hypertension (P <.0001, <.0001, <.001,.004,.0008,.002,.008,.009,.053, and.01, respectively) and a lower prevalence of interstitial lung disease (P <.0001). Conclusions CR is a common PFT pattern with distinct clinical features. The associated clinical entities share impaired lung emptying (eg, neuromuscular disease, occult obstruction, chest wall limitation). Clinicians should be aware of this novel PFT pattern and how it shapes the differential diagnosis.
KW - PFT
KW - physiology
KW - pulmonary function testing
KW - restrictive disorders
UR - http://www.scopus.com/inward/record.url?scp=85038257527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038257527&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2017.07.009
DO - 10.1016/j.chest.2017.07.009
M3 - Article
C2 - 28728932
AN - SCOPUS:85038257527
SN - 0012-3692
VL - 152
SP - 1258
EP - 1265
JO - Diseases of the chest
JF - Diseases of the chest
IS - 6
ER -